Skip to main content

Advertisement

Log in

Management of punding in Parkinson’s disease: an open-label prospective study

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Punding, a peculiar stereotyped behavior characterized by intense fascination with complex, excessive, non-goal-oriented, repetitive activities, is a quite rare condition complicating Parkinson’s disease (PD). It is triggered by dopaminergic therapy and could have a strong impact on patient quality of life. No study has specifically investigated medical management of this condition, and only a few anecdotal reports have provided therapeutic hints. Given the suggested similarities to drug-induced dyskinesias, we have previously suggested a multistep algorithm for management of punding. We conducted a prospective open-label study on ten PD punders aimed at testing its validity. In two cases, reduction of levodopa therapy was efficacious; amantadine was effective in controlling punding in four cases; in the remaining cases, quetiapine was employed, with mild efficacy in two cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

PD:

Parkinson’s disease

References

  1. Evans AH, Katzenschlager R, Paviour D, O’Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405

    Article  PubMed  Google Scholar 

  2. Fasano A, Petrovic I (2010) Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatry 15:560–573

    Article  PubMed  CAS  Google Scholar 

  3. Rylander G (1972) Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 75:203–212

    PubMed  CAS  Google Scholar 

  4. Fasano A, Barra A, Nicosia P, Rinaldi F, Bria P, Bentivoglio AR, Tonioni F (2008) Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding. Drug Alcohol Depend 96:178–182

    Article  PubMed  CAS  Google Scholar 

  5. Friedman JH (1994) Punding on levodopa. Biol Psychiatry 36:350–351

    Article  PubMed  CAS  Google Scholar 

  6. Fernandez HH, Friedman JH (1999) Punding on L-dopa. Mov Disord 14:836–838

    Article  PubMed  CAS  Google Scholar 

  7. (2002) Amantadine and other antiglutamate agents: management of Parkinson’s disease. Mov Disord 17 (Suppl 4):13–22

  8. Kashihara K, Imamura T (2008) Amantadine may reverse punding in Parkinson’s disease—observation in a patient. Mov Disord 23:129–130

    Article  PubMed  Google Scholar 

  9. Jankovic J (2005) Motor fluctuations and dyskinesias in Parkinson’s disease: clinical manifestations. Mov Disord 20 (Suppl 11):11–16

    Google Scholar 

  10. Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ (2006) Punding and dyskinesias. Mov Disord 21:2214–2217

    Article  PubMed  Google Scholar 

  11. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39

    Article  PubMed  CAS  Google Scholar 

  12. Aubert I, Guigoni C, Hakansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E (2005) Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol 57:17–26

    Article  PubMed  CAS  Google Scholar 

  13. Kimber TE, Thompson PD, Kiley MA (2008) Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson’s disease. J Clin Neurosci 15:205–208

    Article  PubMed  CAS  Google Scholar 

  14. Kalivas PW (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10:561–572

    Article  PubMed  CAS  Google Scholar 

  15. Thomas A, Bonanni L, Gambi F, Di Iorio A, Onofrj M (2010) Pathological gambling in PD is reduced by amantadine. Ann Neurol (in press)

  16. Fasano A, Elia AE, Soleti F, Guidubaldi A, Bentivoglio AR (2006) Punding and computer addiction in Parkinson’s disease. Mov Disord 21:1217–1218

    Article  PubMed  Google Scholar 

  17. Miwa H, Morita S, Nakanishi I, Kondo T (2004) Stereotyped behaviors or punding after quetiapine administration in Parkinson’s disease. Parkinsonism Relat Disord 10:177–180

    Article  PubMed  Google Scholar 

  18. Durif F, Vidailhet M, Assal F, Roche C, Bonnet AM, Agid Y (1997) Low-dose clozapine improves dyskinesias in Parkinson’s disease. Neurology 48:658–662

    PubMed  CAS  Google Scholar 

  19. Fasano A, Pettorruso M, Ricciardi L, Conte G, Bentivoglio AR (2010) Punding in Parkinson’s disease: the impact of patient’s awareness on diagnosis. Mov Disord 25:1297–1299

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest or financial disclosures.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Fasano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fasano, A., Ricciardi, L., Pettorruso, M. et al. Management of punding in Parkinson’s disease: an open-label prospective study. J Neurol 258, 656–660 (2011). https://doi.org/10.1007/s00415-010-5817-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-010-5817-8

Keywords

Navigation